Th1 and Th9 cells in the TME boost CD8+ T cells’ ability to fight tumors, mainly by secreting IL-4 and IFN-γ, which are linked to a favorable prognosis in various cancer types [9,42]. This evidence concerns the gene IL4 and cancer.